Coenzyme Q10 / ECM/TCF Cancer Research Results

CoQ10, Coenzyme Q10: Click to Expand ⟱
Features:
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a fat-soluble antioxidant and a critical component of the mitochondrial electron transport chain, essential for ATP production. Its potential role in Alzheimer’s disease (AD) and cancer has been increasingly studied, mainly due to its effects on oxidative stress, mitochondrial function, and cellular energy metabolism.

Two types: ubiquinone(standard) vs ubiquinol(more bioavailable)

-high content in beef heart -Acts as an antioxidant, reducing ROS
-Some preclinical studies suggest CoQ10 may reduce Aβ-induced neurotoxicity
-CoQ10 is sometimes used with chemotherapy to reduce cardiotoxicity (especially with doxorubicin).
-Essential for ATP (energy) production.

-CoQ10 levels may drop by 25–40% in people taking statins.
-May support mitochondrial function in neurodegenerative diseases, including Alzheimer’s and Parkinson’s

Coenzyme Q10 exists in three redox states:
Form	         Name	          Abbreviation	Redox state
Oxidized	Ubiquinone	    CoQ10	Oxidized (labeled “Coenzyme Q10”, “CoQ10”)
Semiquinone	Ubiquinol radical   CoQ10•–	Intermediate (labeled “Ubiquinol”, “Reduced CoQ10”)
Reduced	        Ubiquinol	    CoQ10H₂	Reduced

Most supplements = ubiquinol (reduced, antioxidant)
  Ubiquinol is often preferred for cardiovascular, aging, and antioxidant-focused use.
BPM31510 = ubiquinone (oxidized) (might raise ROS in cancer cells)

>80–95% of circulating CoQ10 is ubiquinol, regardless of whether ubiquinone or ubiquinol was ingested

-CoQ10 is fat-soluble, so take it alongside meals that include nutrient-dense fats like coconut oil, butter or tallow in moderation
-initial 200-300mg/day (split during day) down to 100mg after 21 days

BPM31510: Pharmaceutical oxidized CoQ10
BPM31510 = oxidized CoQ10 (ubiquinone) in a specialized lipid formulation.
BPM31510 increases Mitochondrial ROS in cancer cells. That increase is intentional, central to its mechanism, and relatively selective for tumor cells.
BPM31510 Studies report in cancer cells:
↑ mitochondrial ROS
↑ lipid peroxidation
↓ NADPH/NADP⁺ ratio
↓ GSH/GSSG ratio
Activation of oxidative stress pathways
Cell death without classic antioxidant rescue
Importantly: Trolox, NAC, or GSH can partially blunt BPM31510 effects, confirming ROS dependence

Coenzyme Q10 (CoQ10 / Ubiquinone) — Cancer vs Normal Cell Effects
Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Mitochondrial electron transport (ETC) ↔ or ↓ metabolic advantage ↑ ETC efficiency Driver Mitochondrial bioenergetic support CoQ10 improves electron transport and ATP efficiency primarily in normal cells
2 Reactive oxygen species (ROS) ↓ ROS (antioxidant) ↓ ROS (strong buffering) Driver Antioxidant dominance CoQ10 limits lipid peroxidation and mitochondrial ROS production
3 Mitochondrial membrane stability ↔ stabilized (may reduce stress signaling) ↑ membrane protection Secondary Mitochondrial resilience Stabilization favors normal cells and may blunt oxidative stress-based cancer therapies
4 Inflammatory signaling (NF-κB / cytokines) ↓ inflammatory microenvironment ↓ inflammation Secondary Anti-inflammatory milieu Reduced inflammation may limit tumor promotion but is not directly cytotoxic
5 Cell proliferation ↔ or mildly ↓ ↔ Phenotypic Growth neutrality CoQ10 does not strongly inhibit proliferation in most cancer models
6 Apoptosis ↓ apoptosis (stress protection) ↓ apoptosis Phenotypic Cytoprotection Anti-apoptotic effect reflects antioxidant and mitochondrial protection


ECM/TCF, Endothelial cell migration/tip cell formation: Click to Expand ⟱
Source: HalifaxProj(inhibit)
Type:
Endothelial cell migration and tip cell formation are critical processes in angiogenesis, the formation of new blood vessels from pre-existing ones. These processes are particularly relevant in the context of cancer, where tumor growth and metastasis often depend on the development of a robust blood supply.
Tumors often secrete pro-angiogenic factors, such as VEGF, to stimulate the formation of new blood vessels. This process allows tumors to obtain the necessary nutrients and oxygen for growth and provides a route for cancer cells to enter the bloodstream and metastasize.
Many tumors overexpress VEGF to stimulate angiogenesis, allowing for increased blood supply to support tumor growth. High levels of VEGF are often associated with poor prognosis in various cancers.
Scientific Papers found: Click to Expand⟱
4770- CoQ10,  VitK2,    Cancer cell stiffening via CoQ10 and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer
- in-vitro, BC, MDA-MB-231
other↑, *antiOx↑, Risk↓, other↑, TumMeta↓, ECM/TCF↓, Akt2↓, Ferroptosis↑, eff↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

Ferroptosis↑, 1,  

Cell Death ⓘ

Ferroptosis↑, 1,  

Transcription & Epigenetics ⓘ

other↑, 2,  

Migration ⓘ

Akt2↓, 1,   TumMeta↓, 1,  

Angiogenesis & Vasculature ⓘ

ECM/TCF↓, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 1,  

Functional Outcomes ⓘ

Risk↓, 1,  
Total Targets: 8

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 1,  
Total Targets: 1

Scientific Paper Hit Count for: ECM/TCF, Endothelial cell migration/tip cell formation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:356  Target#:99  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page